However, this is not in line with recent reviews evaluating CI performance in subjects with TMPRSS3-associated sensorineural hearing loss (SNHL) reporting overall beneficial outcomes. This evidence concerns the gene TMPRSS3 and sensorineural hearing loss disorder.